These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23226062)

  • 1. ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics.
    Barratt DT; Coller JK; Hallinan R; Byrne A; White JM; Foster DJ; Somogyi AA
    Pharmgenomics Pers Med; 2012; 5():53-62. PubMed ID: 23226062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCB1 Polymorphisms and Cold Pressor Pain Responses: Opioid-Dependent Patients on Methadone Maintenance Therapy.
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Nurs Res; 2017; 66(2):134-144. PubMed ID: 28252574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females.
    Rahikainen AL; Palo JU; Haukka J; Sajantila A
    Pharmacogenet Genomics; 2018 Apr; 28(4):99-106. PubMed ID: 29481489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ABCB1 most frequent polymorphisms on the accumulation of bictegravir in recombinant HEK293 cell lines.
    De Greef J; Akue M; Panin N; Delongie KA; André M; Mahieu G; Hoste E; Elens L; Belkhir L; Haufroid V
    Sci Rep; 2024 Jul; 14(1):16290. PubMed ID: 39009738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT).
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Am J Drug Alcohol Abuse; 2016 Sep; 42(5):587-596. PubMed ID: 27284701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
    Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
    Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals.
    Coller JK; Barratt DT; Dahlen K; Loennechen MH; Somogyi AA
    Clin Pharmacol Ther; 2006 Dec; 80(6):682-90. PubMed ID: 17178268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
    Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
    Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney Transplantation.
    Hu R; Barratt DT; Coller JK; Sallustio BC; Somogyi AA
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):320-326. PubMed ID: 29603629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone Dosage and Plasma Levels, SNPs of OPRM1 Gene and Age of First Drug Use Were Associated With Outcomes of Methadone Maintenance Treatment.
    Peng S; Jiang H; Du J; Lin S; Pan S; Yu S; Zhao M
    Front Genet; 2018; 9():450. PubMed ID: 30420869
    [No Abstract]   [Full Text] [Related]  

  • 11. Beyond Single Nucleotide Polymorphisms:
    Brazeau DA; Attwood K; Meaney CJ; Wilding GE; Consiglio JD; Chang SS; Gundroo A; Venuto RC; Cooper L; Tornatore KM
    Front Genet; 2020; 11():889. PubMed ID: 32849848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics biomarkers for personalized methadone maintenance treatment: The mechanism and its potential use.
    Ramli FF
    Bosn J Basic Med Sci; 2021 Apr; 21(2):145-154. PubMed ID: 32841585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
    Tan DQ
    Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study.
    AlMeman AA; Ismail R; Perola M
    Drug Metab Lett; 2016; 10(3):213-218. PubMed ID: 27515451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines.
    Sennesael AL; Panin N; Vancraeynest C; Pochet L; Spinewine A; Haufroid V; Elens L
    Sci Rep; 2018 Jul; 8(1):10514. PubMed ID: 30002384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
    Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY
    Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid.
    Rychlik-Sych M; Barańska M; Dudarewicz M; Skrętkowicz J; Żebrowska A; Woźniacka A; Owczarek J; Orszulak-Michalak D; Waszczykowska E
    Arch Dermatol Res; 2018 Aug; 310(6):515-522. PubMed ID: 29948283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of four ABCB1 genetic polymorphisms on the accumulation of darunavir in HEK293 recombinant cell lines.
    Stillemans G; Djokoto HP; Delongie KA; El-Hamdaoui H; Panin N; Haufroid V; Elens L
    Sci Rep; 2021 Apr; 11(1):9000. PubMed ID: 33903659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Firfirey F; September AV; Shamley D
    Pharmacogenomics; 2022 Jun; 23(9):513-530. PubMed ID: 35727214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.